Five serious COVID patients recover after experimental Israeli treatment

Times of Israel | Oct 1, 2020 at 9:03 PM
  • Israeli immunotherapy company Enlivex Therapeutics said Thursday that five COVID-19 patients in severe to critical condition recovered from the disease within days after receiving its experimental treatment.
  • The three subjects in severe condition were released from the hospital 5.5 days after receiving the treatment, and the two patients in critical condition were released after 8.5 days.
  • The company previously demonstrated the drug’s safety in treating a small group of sepsis patients, and now plans to launch Phase II clinical trials for coronavirus patients in severe or critical condition.